Your browser doesn't support javascript.
loading
Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor.
Wang, Xi-Xi; Feng, Ya; Li, Xuan; Zhu, Xiao-Ying; Truong, Daniel; Ondo, William G; Wu, Yun-Cheng.
Afiliação
  • Wang XX; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Feng Y; Shanghai General Hospital of Nanjing Medical University, Nanjing, China.
  • Li X; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhu XY; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Truong D; Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ondo WG; Orange Coast Memorial Medical Center, The Truong Neurosciences Institute, Fountain Valley, CA, United States.
  • Wu YC; Department of Neurosciences and Psychiatry, University of California, Riverside, Riverside, CA, United States.
Front Neurol ; 11: 874, 2020.
Article em En | MEDLINE | ID: mdl-32982913
ABSTRACT

Background:

Essential tremor (ET) is manifested as an isolated syndrome of bilateral upper limb action tremor. Parkinson's disease (PD) is the second most common neurodegenerative disease, with typical motor symptoms of bradykinesia, rigidity, and resting tremor. ET-PD describes the new-onset of PD in ET patients. Recently, numerous studies on epidemiology, genetics, pathology, clinical features, and neuroimaging studies are challenging the idea that ET is an isolated disease, suggesting that patients with ET have the tendency to develop PD.

Methods:

In this review article, we collected recent findings that reveal prodromal markers of PD in patients with ET.

Results:

Substantia nigra hyperechogenicity serves as a prodromal marker for predicting the development of PD in patients with ET and provides a reference for therapeutic strategies. Additional potential markers include other neuroimaging, clinical features, heart rate, and genetics, whereas others lack sufficient evidence.

Conclusion:

In consideration of the limited research of PD in patients with ET, we are still far from revealing the prodromal markers. However, from the existing follow-up studies on ET patients, Substantia nigra hyperechogenicity may enable further exploration of the relationship between ET and PD and the search for pathogenesis-based therapies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
...